PMID- 15828119
OWN - NLM
STAT- MEDLINE
DCOM- 20050418
LR  - 20140825
IS  - 1058-708X (Print)
IS  - 1058-708X (Linking)
VI  - 17
IP  - 2
DP  - 2005 Winter
TI  - Immune reconstitution syndrome.
PG  - 12-5
AB  - Immune reconstitution, or the reversal of HIV-related immune system decline, is 
      one of the primary goals of highly active antiretroviral therapy (HAART). 
      Reconstitution involves an increase in functional CD4 cells to guide the immune 
      response against pathogens such as HIV, resulting in the suppression of viral 
      load and other beneficial outcomes. However, immune reconstitution may trigger an 
      inflammatory reaction in some people soon after they begin anti-HIV therapy and 
      show signs of immunological improvement. Known as immune reconstitution syndrome 
      (IRS) or immune reconstitution inflammatory syndrome (IRIS), this set of symptoms 
      often resembles an AIDS-defining illness or other condition seen in people with 
      HIV. While in most cases the symptoms of IRIS resolve after a few weeks, the 
      syndrome may be severe or mistaken for true disease progression, and should be 
      properly diagnosed and treated.
FAU - Cheonis, Nicholas
AU  - Cheonis N
LA  - eng
PT  - Newspaper Article
PL  - United States
TA  - BETA
JT  - BETA : bulletin of experimental treatments for AIDS : a publication of the San 
      Francisco AIDS Foundation
JID - 9113964
MH  - CD4 Lymphocyte Count
MH  - HIV Infections/*drug therapy/*immunology
MH  - Humans
MH  - Incidence
MH  - Syndrome
EDAT- 2005/04/15 09:00
MHDA- 2005/04/19 09:00
CRDT- 2005/04/15 09:00
PHST- 2005/04/15 09:00 [pubmed]
PHST- 2005/04/19 09:00 [medline]
PHST- 2005/04/15 09:00 [entrez]
PST - ppublish
SO  - BETA. 2005 Winter;17(2):12-5.